Envestnet Asset Management
BHVN

Envestnet Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Envestnet Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,174
Closed -$480K – 4146
2022
Q3 		$480K Sell
3,174
-30,030
-90% -$4.45M ﹤0.01% 3043
2022
Q2 		$4.84M Buy
33,204
+3,355
+11% +$429K ﹤0.01% 1542
2022
Q1 		$3.54M Buy
29,849
+3,305
+12% +$412K ﹤0.01% 1820
2021
Q4 		$3.66M Buy
26,544
+21,925
+475% +$2.79M ﹤0.01% 1773
2021
Q3 		$642K Buy
4,619
+856
+23% +$107K ﹤0.01% 2816
2021
Q2 		$365K Buy
3,763
+294
+8% +$23.9K ﹤0.01% 3170
2021
Q1 		$237K Buy
3,469
+776
+29% +$62.8K ﹤0.01% 3257
2020
Q4 		$231K Buy
+2,693
New +$228K ﹤0.01% 3061
2020
Q3 		– Sell
-3,535
Closed -$258K – 3253
2020
Q2 		$258K Buy
+3,535
New +$188K ﹤0.01% 2756
2019
Q2 		– Sell
-3,877
Closed -$200K – 3140
2019
Q1 		$200K Buy
+3,877
New +$167K ﹤0.01% 2836
2018
Q3 		– Sell
-1,226
Closed -$48K – 3206
2018
Q2 		$48K Buy
1,226
+140
+13% +$4.44K ﹤0.01% 2222
2018
Q1 		$28K Buy
1,086
+552
+103% +$16.5K ﹤0.01% 2300
2017
Q4 		$14K Sell
534
-559
-51% -$15.4K ﹤0.01% 2582
2017
Q3 		$41K Buy
1,093
+104
+11% +$3.15K ﹤0.01% 2336
2017
Q2 		$25K Buy
+989
New +$22.8K ﹤0.01% 2555

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Envestnet Asset Management's BHVN Position: Q4 2022 in Review

Envestnet Asset Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 3,174 shares — an estimated $480K sold.

Envestnet Asset Management first reported a position in BHVN in Q2 2017 and held it in 15 quarters. The position peaked at $4.84M in Q2 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Envestnet Asset Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Envestnet Asset Management sold 3,174 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $480K.
  • Envestnet Asset Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 15 quarters.
  • Envestnet Asset Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $4.84M in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Envestnet Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.